• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺素能受体亚型在上睑提肌中的分布。

Distribution of adrenergic receptor subtypes in the retractor muscles of the upper eyelid.

作者信息

Esmaeli-Gutstein B, Hewlett B R, Pashby R C, Oestreicher J, Harvey J T

机构信息

Department of Ophthalmology, McMaster University, Hamilton, Ontario, Canada.

出版信息

Ophthalmic Plast Reconstr Surg. 1999 Mar;15(2):92-9. doi: 10.1097/00002341-199903000-00005.

DOI:10.1097/00002341-199903000-00005
PMID:10189635
Abstract

PURPOSE

To identify adrenergic receptor subtypes and their relative distribution in the retractor muscles of the upper eyelid, the levator palpebrae superioris, and the Müller muscle. The pattern of distribution of these receptors in the Müller muscle was further compared in patients with dysthyroid eyelid retraction and in normal subjects.

METHODS

Müller muscle specimens were collected from 19 patients undergoing ptosis correction and from 8 patients undergoing repair of dysthyroid eyelid retraction. Immunohistochemical staining for alpha 1-, alpha 2-, beta 1-, and beta 2-adrenergic receptors was performed using antihuman rabbit polyclonal antibodies.

RESULTS

alpha 2-Adrenergic receptors were the predominant subtype in the Müller muscle, and beta 1-adrenergic receptors were the predominant subtype in the levator muscle. There was no significant difference in the staining pattern between specimens collected from patients with dysthyroid eyelid retraction and those from normal subjects.

CONCLUSIONS

The interaction between the alpha 2 and beta 1 receptors in the upper eyelid retractor muscles may be important in the control of the upper eyelid position and may contribute to the development of dysthyroid eyelid retraction. Specific alpha 2 antagonists could be developed and may be effective pharmacologic agents for the treatment of eyelid retraction.

摘要

目的

确定肾上腺素能受体亚型及其在上睑提肌、上睑退缩肌和米勒肌中的相对分布。并对甲状腺功能异常性上睑退缩患者和正常受试者米勒肌中这些受体的分布模式进行进一步比较。

方法

从19例接受上睑下垂矫正手术的患者和8例接受甲状腺功能异常性上睑退缩修复手术的患者中采集米勒肌标本。使用抗人兔多克隆抗体对α1、α2、β1和β2肾上腺素能受体进行免疫组织化学染色。

结果

α2肾上腺素能受体是米勒肌中的主要亚型,β1肾上腺素能受体是提上睑肌中的主要亚型。甲状腺功能异常性上睑退缩患者和正常受试者的标本染色模式无显著差异。

结论

上睑退缩肌中α2和β1受体之间的相互作用可能对上睑位置的控制很重要,并可能导致甲状腺功能异常性上睑退缩的发生。可以开发特异性α2拮抗剂,其可能是治疗上睑退缩的有效药物。

相似文献

1
Distribution of adrenergic receptor subtypes in the retractor muscles of the upper eyelid.肾上腺素能受体亚型在上睑提肌中的分布。
Ophthalmic Plast Reconstr Surg. 1999 Mar;15(2):92-9. doi: 10.1097/00002341-199903000-00005.
2
Levator palpebrae superioris muscle: MR evaluation of enlargement as a cause of upper eyelid retraction in Graves disease.提上睑肌:磁共振成像评估提上睑肌增粗作为Graves病上睑退缩的病因
Radiology. 1993 Jul;188(1):115-8. doi: 10.1148/radiology.188.1.8511284.
3
Adrenergic receptors in the ptotic human eyelid: correlation with phenylephrine testing and surgical success in ptosis repair.上睑下垂患者上睑的肾上腺素能受体:与去氧肾上腺素试验及上睑下垂修复手术成功率的相关性
Ophthalmic Plast Reconstr Surg. 2007 Sep-Oct;23(5):367-71. doi: 10.1097/IOP.0b013e3181462a2e.
4
The functional and histopathologic change in the levator palpebrae superioris and Müller muscle after subconjunctival injection of triamcinolone acetonide.结膜下注射曲安奈德后上睑提肌和米勒肌的功能及组织病理学变化。
J Craniofac Surg. 2015 Jan;26(1):285-9. doi: 10.1097/SCS.0000000000001174.
5
Results of Müllerotomy and levator aponeurosis transposition for the correction of upper eyelid retraction in Graves disease.米勒氏肌切开术联合提上睑肌腱膜转位矫正Graves病上睑退缩的效果
Ophthalmology. 1995 Mar;102(3):483-92. doi: 10.1016/s0161-6420(95)30996-7.
6
Levator Muscle Enlargement in Thyroid Eye Disease-Related Upper Eyelid Retraction.甲状腺眼病相关上睑退缩中的提上睑肌增大
Ophthalmic Plast Reconstr Surg. 2017 Jan/Feb;33(1):35-39. doi: 10.1097/IOP.0000000000000633.
7
Correction of postoperative eyelid retraction with a simplified levator palpebrae superioris (LPS) muscle recession: analysis of a 10-year experience.简化提上睑肌(LPS)肌肉后徙术矫正术后眼睑退缩:10年经验分析
Ophthalmic Surg. 1987 Nov;18(11):815-20.
8
Relationships between eyelid position and levator-superior rectus complex and inferior rectus muscle in patients with Graves' orbitopathy with unilateral upper eyelid retraction.Graves眼病单侧上睑退缩患者眼睑位置与提上睑肌-上直肌复合体及下直肌之间的关系
Graefes Arch Clin Exp Ophthalmol. 2018 Oct;256(10):2001-2008. doi: 10.1007/s00417-018-4056-z. Epub 2018 Jun 29.
9
Levator excursion as a predictor of both eyelid lag and lagophthalmos in thyroid eye disease.提上睑肌位移可预测甲状腺相关眼病的眼睑迟滞和兔眼。
Ophthalmic Plast Reconstr Surg. 2010 Jan-Feb;26(1):7-10. doi: 10.1097/IOP.0b013e3181b8e08d.
10
Palpebral fissure height and downgaze in patients with Graves upper eyelid retraction and congenital blepharoptosis.格雷夫斯上睑退缩和先天性上睑下垂患者的睑裂高度和向下注视情况
Ophthalmology. 1995 Aug;102(8):1218-22. doi: 10.1016/s0161-6420(95)30887-1.

引用本文的文献

1
Efficacy of Oxymetazoline 0.1% in Acquired Blepharoptosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.0.1%羟甲唑啉治疗后天性上睑下垂的疗效:一项随机临床试验的系统评价和荟萃分析
Clin Ophthalmol. 2025 Aug 23;19:2955-2964. doi: 10.2147/OPTH.S529633. eCollection 2025.
2
Efficacy of Transconjunctival Tucking Surgery in Comparison With the Phenylephrine-test Positive and Negative Involutional Blepharoptosis Groups.经结膜折叠手术与去氧肾上腺素试验阳性和阴性的退行性上睑下垂组相比的疗效
Plast Reconstr Surg Glob Open. 2025 Jul 16;13(7):e6902. doi: 10.1097/GOX.0000000000006902. eCollection 2025 Jul.
3
Palpebral Fissure Response to Phenylephrine Indicates Autonomic Dysfunction in Patients With Type 1 Diabetes and Polyneuropathy.
上睑裂反应对苯肾上腺素表明自主神经功能障碍在 1 型糖尿病和多发性神经病患者。
Invest Ophthalmol Vis Sci. 2022 Aug 2;63(9):21. doi: 10.1167/iovs.63.9.21.
4
An Alternative Algorithm for Müller Muscle Conjunctival Resection Surgery for Blepharoptosis Management.一种用于上睑下垂治疗的 Müller 肌结膜切除术的替代算法。
Beyoglu Eye J. 2019 Dec 23;4(3):172-178. doi: 10.14744/bej.2019.46220. eCollection 2019.
5
Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials.0.1%盐酸羟甲唑啉滴眼液每日一次给药在后天性上睑下垂患者中的安全性:四项随机双盲临床试验结果
Clin Ophthalmol. 2021 Oct 8;15:4035-4048. doi: 10.2147/OPTH.S322326. eCollection 2021.
6
Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results.0.1% 羟甲唑啉治疗获得性上睑下垂的快速持续上睑提升:随机 3 期试验结果
Clin Ophthalmol. 2021 Jun 25;15:2743-2751. doi: 10.2147/OPTH.S306155. eCollection 2021.
7
A review of acquired blepharoptosis: prevalence, diagnosis, and current treatment options.获得性上睑下垂的综述:患病率、诊断和当前治疗选择。
Eye (Lond). 2021 Sep;35(9):2468-2481. doi: 10.1038/s41433-021-01547-5. Epub 2021 Apr 29.
8
Lower lid entropion secondary to treatment with alpha-1a receptor antagonist: a case report.α-1a受体拮抗剂治疗继发下睑内翻:一例报告
J Med Case Rep. 2010 Mar 2;4:77. doi: 10.1186/1752-1947-4-77.